Triosephosphate isomerase

BE0003844ProteinHumansTPI1

Triosephosphate isomerase is an extremely efficient metabolic enzyme that catalyzes the interconversion between dihydroxyacetone phosphate (DHAP) and D-glyceraldehyde-3-phosphate (G3P) in glycolysis and gluconeogenesis. It is acted on by 17 drugs in DrugBank.

Gene name
TPI1
UniProtKB entry
P60174Swiss-Prot
Cellular location
Cytoplasm
Residues / weight
249 residues · 26,669 Da
Also known as
5.3.1.1 · Methylglyoxal synthase · TIM · TPI · Triose-phosphate isomerase

Resolves to

Pharmacology

What you can answer from here — as of September 07, 2019

17DrugsApproved to experimental, with action, bond type and pharmacological action
Sign in
9GO termsFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
53+ReferencesStructured and connected to the statements they support
Sign in

Which approved drugs act on Triosephosphate isomerase, how selective are they, and which programs against it are still in active trials?

Create a free account or log in to explore the full data card.

Create Account